Clinical trials: Polycythemia, Primary

Myeloproliferative Diseases

Pacritinib Before Transplant for Myeloproliferative Neoplasms (MPN)

• Terminated
• Age: 18 to 70 years
• Phase 2
• Surgery or procedure
• Lifestyle or therapy programme
• Results posted

The goal of this clinical research study is to learn if giving pacritinib before standard of care drugs followed by an allogeneic stem cell transplant can help to control myeloproliferative neoplasms.

Trial name

NCT02410551

Testing

Pacritinib, Busulfan, Questionnaires

Where

United States

Volunteers

4 people

Sponsor

M.D. Anderson Cancer Center